Table 1.
Demographics and clinical features of patients with psoriasis and healthy controls.
| Patients with Psoriasis (n = 98) | Healthy Controls (n = 20) | Patients with Skin Cancers (n = 15) | |
|---|---|---|---|
| Sex (N,%) | |||
| Female Male |
39 (39.8) 59 (60.2) |
12 (60) 8 (40) |
9 (60) 6 (40) |
| Age | |||
| mean ± SD (range) |
53.8 ± 18.2 (19–93) |
56.5 ± 10.6 (37–74) |
68.8 ± 17.9 (38–95) |
| Family history of psoriasis | |||
| (N,%) | 50 (51.0) | 0 (100) | 0 (100) |
| Family history of NMSC (N,%) | 17 (17.3) | 0 (100) | 3 (20) |
| Family history of melanoma (N,%) | 1 (1.0) | 0 (100) | 1 (6.7) |
| Fitzpatrick’s type (N,%) | |||
| I II III |
1 (2.0) 73 (74.5) 24 (24.5) |
0 (0) 16 (80) 4 (20) |
1 (6.7) 10 (66.7) 4 (26.6) |
| Type of psoriasis (N,%) | |||
|
Plaque Psoriasis
Guttate Psoriasis Palmo-plantar Psoriasis Inverse Psoriasis Combination of two or more types |
70 (71.4) 8 (8.2) 5 (5.1) 5 (5.1) 10 (10.2) |
- | - |
| Disease duration (years) | |||
| mean ± SD (range) |
17.5 ± 11.1 (1–49) |
- | - |
| PASI score | |||
| Total Female Male (range) |
8.5 8 7.9 (2–17) |
- | - |
| NMSC (N,%) | |||
| Total Female Male |
15 (15.3) 6 (40) 9 (60) |
- | 12 (80) 8 (53.3) 4 (26.7) |
| Melanoma (N,%) | - | ||
| Total Female Male |
8 (53.3) 3 (37.5) 5 (62.5) |
3 (20) 2 (66.7) 1 (33.3) |
NMSC = non melanoma skin cancers; PASI = psoriasis area and severity index score; -: none.